Immunodiagnostic Systems Holdings plc (IDS) manufactures and distributes medical diagnostic products. The Company is also actively involved in research and development projects. Its range of products includes bone and growth-related products. The principal products of IDS continue to be kits for the determination of vitamin D in human serum. IDS operates in the immunoassay segment of the in vitro diagnostics (IVD) market. Its product areas of investigation includes autoimmune disease, biogenic amines, bone and mineral metabolism, cytokines and adhesion molecules, diabetes, endocrinology, growth, instrumentation, inflammation and infection, neuroedocrinology, and pre clinical and veterinary studies. Effective June 30, 2007, the Company acquired Nordic Bioscience Diagnostics A/S. Effective August 31, 2007, it completed the acquisition of 99.93% interest in Biocode Hycel S.A. In January 2009, it completed the sale of IDS Biocode Hycel’s haematology business to Escalon Medical Corporation.